Premier test PCR du Maroc pour la mpox approuvé par Africa CDC
Addis-Abeba, Éthiopie, le 12 novembre 2024 – Le Centre Africain de Contrôle et de Prévention des Maladies (Africa CDC), à travers son Comité Consultatif des Diagnostiques (DAC), a recommandé le premier test PCR en temps réel pour la mpox fabriqué localement au Maroc. L’approbation par Africa CDC souligne la fiabilité et l’efficacité de ce test, […]
Singapore’s Health Ministry and Africa CDC Announce Joint Efforts to Tackle the Mpox Outbreak
Singapore, Addis Ababa, 15 November, 2024 – To strengthen the Africa Centres for Disease Control and Prevention’s (Africa CDC) capacity for enhanced mpox case management, the Ministry of Health, Singapore will provide a support package consisting of mpox diagnostic kits and testing supplies, enabling up to 50,000 tests. The ongoing mpox outbreak was declared a […]
Morocco’s First Homegrown PCR Test for mpox Gets Africa CDC Nod
Addis Ababa, Ethiopia, 12 Nov 2024 – The Africa Centres for Disease Control and Prevention through its Diagnostic Advisory Committee (DAC) has recommended the first locally manufactured Real-Time PCR test for mpox from Morocco. Africa CDC’s approval underscores the test’s reliability and efficacy, potentially boosting Morocco’s role in global health initiatives. This major milestone is […]
WHO, Africa CDC support 17 countries to develop mpox vaccination plans
Brazzaville, Congo – World Health Organization (WHO) and Africa Centres for Disease Control and Prevention (Africa CDC) experts gathered in Brazzaville this week with country representatives and partners to provide guidance for the development of targeted mpox vaccine preparedness and deployment plans to ensure that available doses are used efficiently. In anticipation of further mpox […]
Driving Pan-African Research Collaboration: PANTHER and Africa CDC Launch the Mpox Study in Africa
Addis Ababa, Paris, 7 November 2024 — As critical discussions at the World Health Summit in Berlin conclude, the Africa CDC, in partnership with PANTHER, proudly announces its first direct contribution to the MpOx Study in Africa (MOSA). This pivotal clinical trial aims to advance research for Mpox treatment across the continent. Declared a Public […]
Joint Press Release: Vaccine doses allocated to 9 African countries hardest hit by mpox surge
Addis Ababa/Geneva/New York/Oslo, 5 November 2024 – The Access and Allocation Mechanism (AAM) for mpox has allocated an initial 899 000 vaccine doses for nine countries across the African region that are hit hard by the current mpox surge. In collaboration with affected countries and donors, this decision aims to ensure that the limited doses are […]
Inaugural Global Surveillance Summit 2024, Cape Town, South Africa
Addis Ababa, ETHIOPIA, 29 October 2024 – The Africa Centres for Disease Control and Prevention (Africa CDC) in partnership with the International Society for Infectious Diseases (ISID) will host the inaugural Global Surveillance Summit, an invitational event that will bring together global leaders, innovators, and frontline workers to tackle the challenges posed by new and […]
Joint Press Statement | Global Gateway: EU provides €20 million additional funding towards the Africa CDC-WHO Mpox preparedness and response plan
ADDIS ABABA, 15 October – Jutta Urpilainen, European Commissioner for International Partnerships, has announced an additional €20 million funding towards the fight against Mpox outbreak in the Democratic Republic of the Congo (DRC). This additional funding contributes to the DRC’s Mpox response and supports preparedness against epidemics as part of the EU’s objective to support […]
Global Campaign Launched to Prioritise the Mental Health of Health Professionals on World Mental Health Day
Addis Ababa, ETHIOPIA, 9th October 2024 – This World Mental Health Day, United for Global Mental Health, Africa CDC, the International Council of Nurses (ICN), and the International Federation of Medical Students’ Associations (IFMSA) are launching a global campaign to call for more global attention on the mental health needs of health workers worldwide. The […]
Gilead Sciences, Rwanda’s Ministry of Health and Africa CDC Collaborate to Support Rwanda’s Marburg Virus Disease Response with Antiviral Therapeutic Donation
Addis Ababa, ETHIOPIA, October 8, 2024 – Gilead Sciences, Inc., in collaboration with Africa CDC and Rwanda’s Ministry of Health, has donated 5,100 vials of remdesivir to support Rwanda’s response to the Marburg Virus Disease (MVD). This emergency donation aims to provide treatment to those affected by the virus following negotiations led by Africa CDC. […]